New study explores Dapagliflozin's effects on transplanted kidneys
NCT ID NCT06560801
First seen May 15, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tests whether dapagliflozin, a diabetes drug, can improve kidney structure and blood flow in people with reduced kidney function one year after a kidney transplant. About 48 participants will be randomly assigned to take dapagliflozin or not, and researchers will examine routine biopsy samples and MRI scans. The goal is to understand how the drug affects inflammation, scarring, and blood supply in the transplanted kidney.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Center (CRC)
RECRUITINGErlangen, Bavaria, 91054, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.